4 Suppliers
4 Customers
1 Debt Items
20 Related Chains
Search UTHR in the supply chain database
Create UTHR supply chain alerts
Read UTHR supply chain intel
ORANGE supply chain
NVIDIA Corporation supply chain
Amazon.com, Inc. supply chain
Johnson & Johnson supply chain
Suppliers 4
Clients 4
Debt 1
Acquisitions 0
Ownership 1
Secondary 20
United Therapeutics Corporation Suppliers
Ticker Name Confidence Evidence
CITIBANK-N-A CITIBANK-N-A
On March 9, 2026, the Company entered into two accelerated share repurchase agreements (the ASR Agreements ) with Citibank, N.A. ( Citi ) to repurchase approximately $1.5 billion in the aggregate of …
RAREGEN-LLC RAREGEN-LLC
In April 2019, Sandoz Inc. ( Sandoz ) and its marketing partner RareGen, LLC (now known as Liquidia PAH, LLC, a subsidiary of Liquidia Corporation) ( RareGen ), filed a complaint in the U.S. District…
SMITHS-MEDICAL-ASD-INC SMITHS-MEDICAL-ASD-INC
In April 2019, Sandoz Inc. ( Sandoz ) and its marketing partner RareGen, LLC (now known as Liquidia PAH, LLC, a subsidiary of Liquidia Corporation) ( RareGen ), filed a complaint in the U.S. District…
SUPN Supernus Pharmaceuticals, Inc.
Reciprocal relationship from SUPN graph: Reciprocal relationship from UTHR graph: Reciprocal relationship from SUPN graph: .e., at the time of sale to wholesalers/distributors). This liability is rec…
United Therapeutics Corporation Customers
Ticker Name Confidence Evidence
USGOV-DEPARTMENT-OF-JUSTICE USGOV-DEPARTMENT-OF-JUSTICE
USAspending awards from Department of Justice: $87,006 across 2 awards. 15B50525F00000191 OPSUMIT 10MG-QTY 4 @ $6,270.03 ADEMPAS 1MG, QTY 1 @ $12,153.05 REMODULIN 5MG/ML INJ 20ML VIAL, QTY 1 @ $6,206…
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS
USAspending awards from Department of Veterans Affairs: $651,394 across 8 awards. 36C26124N0646 TYVASO; 36C26024F0248 TYVASO; 36C26026F0064 TYVASO KITS & CARTRIDGES | Qwen corrected direction: Explic…
DISTRIBUTOR-1 DISTRIBUTOR-1
We recorded revenue from two distributors in the United States that exceeded ten percent of total revenues.
DISTRIBUTOR-2 DISTRIBUTOR-2
We recorded revenue from two distributors in the United States that exceeded ten percent of total revenues.
United Therapeutics Corporation Debt Obligations
Instrument Description Confidence Evidence
UTHR-DEBT-13272
Xbrl Convertible
xbrl convertible detail from xbrl 2016-12-31.
United Therapeutics Corporation Acquisitions
No acquisitions on record No completed or pending acquisitions found in our database for United Therapeutics Corporation.
United Therapeutics Corporation Ownership
Holder Name Confidence Evidence
UTHR-OWNER-AVORO-CAPITAL-ADVISORS-LLC
Avoro Capital Advisors LLC
13F overlay lists Avoro Capital Advisors LLC as top holder; 859 tracked holders.
United Therapeutics Corporation Extended Supply Chain Network
Ticker Name Chain Index Hops Relationship Types
EMMA Emmaus Life Sciences, Inc.
100.00 2
GPCR Structure Therapeutics Inc.
100.00 2
SUPN Supernus Pharmaceuticals, Inc.
100.00 1
['supplier']
GSK GSK plc
100.00 2
GOSS Gossamer Bio, Inc.
100.00 2
GWW W.W. Grainger, Inc.
100.00 2
LLY Eli Lilly and Company
100.00 2
JNJ Johnson & Johnson
100.00 2
AZN AstraZeneca PLC
100.00 2
NVSEF Novartis AG
100.00 2
CAH Cardinal Health, Inc.
100.00 2
MCK McKesson Corporation
100.00 2
ELV Elevance Health, Inc.
100.00 2
SANDOZ SANDOZ
50.00 2
FREJP FEDERAL HOME LOAN MORTGAGE CORP
50.00 2
ORANY ORANGE
50.00 2
SYY Sysco Corporation
50.00 2
BIIB Biogen Inc.
50.00 2
COLL Collegium Pharmaceutical, Inc.
50.00 2
FREVS First Real Estate Investment Trust of New Jersey, Inc.
50.00 2
